Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

CBD behind the wheel: new study tests driving safety

NCT ID NCT06686914

First seen Oct 31, 2025 · Last updated Jun 19, 2026 · Updated 31 times

Summary

This study looks at how different doses of CBD oil affect driving performance in 300 healthy adults aged 18-30. Participants will take CBD or a placebo and then use a driving simulator to measure weaving, crashes, and reaction time. The goal is to understand if CBD causes drowsiness or impairs driving, and whether effects differ by dose or sex.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANNABIDIOL EFFECTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • West Virginia University

    RECRUITING

    Morgantown, West Virginia, 26506, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cannabidiol (CBD) oil

What this could lead to

If successful, this could help determine safe CBD doses for driving and inform public safety recommendations.

What could go wrong

This is an early-phase study in healthy volunteers, not patients. Results may not apply to real-world driving or to people with medical conditions.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.